Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of SPARC1103 in Subjects With Spasticity
NCT02027025Phase 2Completed
- Sponsor
- Sun Pharma
- Start
- Apr 2014
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of baclofen in spasticity (3 arms), sponsored by Sun Pharma. Primary endpoint: Modified Ashworth Score at Day 24. Started Apr 2014; status: completed.
02
Drugs
baclofen
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT02027025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02027025.